Latest

Make well informed decisions, quickly through industry leading process simulation, economic analysis software.

Chapter 3: Towards a Sustainable Future with BioSolve

January 16, 2024

Chapter 3: Towards a Sustainable Future with BioSolve – Exciting Developments Ahead! We are thrilled to start 2024 on a high note and share the last instalment of our User Group Forum 2023 Blog with you. This final post highlights the last half of the

Cost Database Update 2023 in BioSolve Process

August 4, 2023

Biopharm Services Cost Database Update 2023 for BioSolve Process is Launched! Our reference Hybrid Mab Process has experienced a 23% increase in manufacturing costs since 2021 First, what is BioSolve Process? Are you developing a new bioprocess or assessing new technology and wondering about the

Chapter 2: Road to Process Model Evolution

July 25, 2023

Chapter 2: Road to Process Model Evolution Landmark on 2nd June in London #processmodelevolution On the second day of the User Group Forum, attendees were welcomed back after a lively and enjoyable networking dinner at a Local Upscale Chinese restaurant. The day began with a

Chapter 1: Process Model Evolution Launch – Landmark on 1st June in London

June 22, 2023

Chapter 1: Process Model Evolution Launch Landmark on 1st June in London Attendees were warmly welcomed on June 1st and 2nd at the elegant Landmark Hotel in London. The event drew participants from afar as Japan (Asahi Kasei and Chugai Pharmaceutical) and Texas, USA (BDO).

Racing Ahead – Pushing forward with Automated Bioproduction Units.

December 14, 2022

Come and see an automated biologics processing unit in operation at a one-day Symposium “Integrated Process Strategies For Regional Biopharmaceutical Supply” on March 28, 2023, Sedgefield, UK. Looking back down the race circuit, the horses don’t seem to be moving quickly – until they come

Biopharm Interview Mr Harvey Branton

June 14, 2022

As you know, Biopharm Services has been part of a UK-based consortium consisting of BiologIC Technologies, CPI, Pall Corporation, and SCIEX. The team has announced the launch of a project that aims to develop automated manufacturing controls for use in the manufacture of biologics. The

Vaccine Manufacturing – how will supply chain complexity effect a distributed vaccine manufacturing network?

December 7, 2021

As of October 2021, 6-7 billion doses of COVID-19 vaccines have been provided under emergency measures. The vaccines roll out has peaked at 45 million doses/day and has remained broadly stable (Our Word in Data & WHO), so we can assume that this is the

Sustainability Interview – Life Cycle Assessment

September 10, 2021

Today we have a special guest – Bill Flanagan to give us great insight into Sustainability in our industry. It is such a pleasure to be able to interview someone who has numerous publications related to sustainability. Our Sales & Marketing Director Dr Yuki Abe

UK biomanufacturing team to spearhead development of advanced controls to accelerate drug and vaccine manufacturing

July 29, 2021

A UK-based consortium consisting of BiologIC Technologies, Biopharm Services, CPI, Pall Corporation, and SCIEX has announced the launch of a project that aims to develop automated manufacturing controls for use in the manufacture of biologics. The project, worth a total of £3.1million, including equipment contributions,

Plasmid DNA, mRNA and Viral Vectors – the Building Blocks of Cell and Gene Therapy Processing

July 28, 2021

The growing pipeline of cell and gene therapy therapies has led to an increase in demand for gene delivery vehicles such as plasmid DNA (pDNA), messenger RNA (mRNA) and viral vectors. They can be used as stand-alone treatments or can be used as starting materials